Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.57 USD | -0.84% | +1.54% | -3.47% |
Apr. 30 | Guggenheim Starts Precision BioSciences With Buy Rating, $19 Price Target | MT |
Apr. 16 | Precision BioSciences Opts to Regain Rights to 3 Programs From Eli Lilly Unit Collaboration | MT |
Evolution of the average Target Price on Precision BioSciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Precision BioSciences, Inc.
Guggenheim | |
HC Wainwright | |
BMO Capital | |
Goldman Sachs | |
Stifel Nicolaus | |
William Blair & Co. | |
BTIG | |
SMBC Nikko | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- DTIL Stock
- Consensus Precision BioSciences, Inc.